Skip to main content
14 Mar | 2022

The BBRC, selected as participating center in a new global study on Alzheimer's

This is the AHEAD clinical trial, an international multicenter study to evaluate the efficacy and safety of lecanemab

11 Mar | 2022

El BBRC participa a la 16a International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

AD / PD 2022, held this year in Barcelona, ​​presents work carried out at the Pasqual Maragall Foundation’s research center, in three oral presentations and a poster. In addition, one of our researchers will moderate a symposium of the congress

09 Mar | 2022

BBRC researchers find that carriers of the APOE-ε4 gene accumulate amyloid early in the hippocampus

The study's innovative design has allowed researchers to detect that carriers of the apoe-ε4 gene, linked to an increased risk of developing Alzheimer's, have an accumulation of early amyloid protein in the hippocampal area

01 Mar | 2022

Carriers of the APOE ε2 gene may have a larger brain reserve and better protection against Alzheimer’s

This has been demonstrated in a study by BBRC researchers, published in Alzheimer's & Dementia, in which they have studied the protective effect against malaise and its link to major volumes of gray matter

25 Feb | 2022

The pioneering project of the Clinical Research Unit in Dementia Prevention is coming to an end

The study, which began in May 2018, looked at the risk of developing dementia five years ahead, in people with subjective memory complaints

16 Feb | 2022

Natàlia Vilor and Oriol Grau receive the Juan de la Cierva scholarship

Juan de la Cierva-Incorporación grants, awarded by the State Research Agency, fund postdoctoral research training in Spanish research centers for three years.

11 Feb | 2022

Oriol Grau, appointed head of the Clinical Research Group and in Risk Factors for Neurodegenerative Diseases

The Clinical Research Group on Risk Factors for Neurodegenerative Diseases will promote research, from an integrative and clinical perspective, in the prevention of Alzheimer's disease and research on healthy aging.

11 Feb | 2022

Gemma Salvadó receives a National Award for the best doctoral thesis on Diagnostic Imaging and Genomics from the QUAES Foundation

Gemma Salvadó joined the BBRC Neuroimaging Group in 2017 as a pre-doctoral researcher, where she collaborated until 2021. She is currently continuing her research on Alzheimer’s at Lund University (Sweden).

11 Feb | 2022

The FPM and the BBRC, with the International Day of Women and Girls in Science

Once again, we support women’s awareness-raising activities in science.